Hematological Impact of Next-Generation PFAS: Evaluation of Coagulation Parameters and Hemostatic Changes in Mice

Clicks: 1
ID: 309148
2025
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #142 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Background: Per- and polyfluoroalkyl substances (PFAS), including next-generation alternatives like GenX and PFBS, are persistent environmental contaminants with emerging evidence of hematological toxicity. While extensively studied for hepatotoxicity and endocrine disruption, their effects on blood coagulation and hemostatic systems remain underexplored. Objective: This review aims to evaluate the impact of next-generation PFAS on coagulation parameters and hemostatic changes in murine models, and to assess their clinical and environmental relevance to human health. Methods: A comprehensive literature review was conducted on studies involving mice exposed to emerging PFAS. Key parameters assessed included prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen levels, platelet counts, and associated molecular mechanisms. Results: Next-generation PFAS, though structurally distinct from legacy compounds, exhibit notable hematological alterations in mice, including prolonged coagulation times and decreased fibrinogen levels. These findings have translational relevance, particularly for populations exposed to contaminated environments. However, gaps in chronic exposure data, biomarker identification, and regulatory consistency remain significant. Conclusion: Next-generation PFAS may pose a hematotoxic risk comparable to or exceeding that of legacy PFAS. Future studies should focus on elucidating mechanisms, validating sensitive biomarkers, and integrating these effects into public health risk assessments.
Reference Key
imported_1761926385_6904dcf1d984f Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Shiv Narayan
Journal International Journal of Pharmaceutical Drug Design (IJPDD)
Year 2025
DOI
10.62896/ijpdd.2.6.07
URL
https://ijpdd.org/index.php/files/article/view/297
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.